Linlei Chen
Overview
Explore the profile of Linlei Chen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
68
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khong K, Liu D, Leung K, Lu L, Lam H, Chen L, et al.
Vaccines (Basel)
. 2022 Feb;
10(2).
PMID: 35214619
By vaccinating SARS-CoV-2 naïve individuals who have already received two doses of COVID-19 vaccines, we aimed to investigate whether a heterologous prime-boost strategy, using vaccines of different platforms as the...
2.
Zhang R, Khong K, Leung K, Liu D, Fan Y, Lu L, et al.
Vaccines (Basel)
. 2021 Dec;
9(12).
PMID: 34960189
Vaccinating recovered patients previously infected by COVID-19 with mRNA vaccines to boost their immune response against wild-type viruses (WT), we aimed to investigate whether vaccine platform and time of vaccination...
3.
Wang X, Lam J, Chen L, Au S, To K, Yuen K, et al.
Emerg Microbes Infect
. 2021 May;
10(1):1016-1023.
PMID: 34003073
Given the on-going SARS-CoV-2 pandemic, identification of immunogenic targets against the viral protein will provide crucial advances towards the development of sensitive diagnostic tools and vaccination strategies. Our previous study...
4.
Lu L, Fong C, Zhang A, Wu W, Li I, Lee A, et al.
Vaccines (Basel)
. 2020 Dec;
8(4).
PMID: 33322574
We previously reported that topical imiquimod can improve the immunogenicity of the influenza vaccine. This study investigated another FDA-approved drug, miltefosine (MTF), as a vaccine adjuvant. Mice immunized with an...
5.
Dong H, Ge X, Shen Y, Chen L, Kong Y, Zhang H, et al.
BMC Med Genomics
. 2009 Jan;
2:5.
PMID: 19171046
Background: Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide and the second cancer killer in China. The initiation and malignant transformation of cancer result from accumulation of...